These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18158483)

  • 41. Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines.
    Kim JH; Studer RK; Sowa GA; Vo NV; Kang JD
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2253-9. PubMed ID: 18784630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion.
    Smirnova MG; Kiselev SL; Gnuchev NV; Birchall JP; Pearson JP
    Eur Cytokine Netw; 2002; 13(2):161-72. PubMed ID: 12101072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach.
    Fernández-Veledo S; Nieto-Vazquez I; Vila-Bedmar R; Garcia-Guerra L; Alonso-Chamorro M; Lorenzo M
    Arch Physiol Biochem; 2009 Oct; 115(4):227-39. PubMed ID: 19673658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted anticytokine therapy and the failing heart.
    Mann DL
    Am J Cardiol; 2005 Jun; 95(11A):9C-16C; discussion 38C-40C. PubMed ID: 15925559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure.
    Haugen E; Täng MS; Isic A; Andersson B; Fu M
    Int J Cardiol; 2008 Oct; 130(1):64-8. PubMed ID: 18280594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokines and myocardial dysfunction: state of the art.
    El-Menyar AA
    J Card Fail; 2008 Feb; 14(1):61-74. PubMed ID: 18226775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiological role of cytokines in congestive heart failure.
    Blum A; Miller H
    Annu Rev Med; 2001; 52():15-27. PubMed ID: 11160765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure.
    Sekiguchi K; Li X; Coker M; Flesch M; Barger PM; Sivasubramanian N; Mann DL
    Cardiovasc Res; 2004 Aug; 63(3):433-42. PubMed ID: 15276468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic heart failure and proinflammatory cytokines: possible role of physical exercise.
    Fuchs M; Drexler H
    Exerc Immunol Rev; 2004; 10():56-65. PubMed ID: 15633586
    [No Abstract]   [Full Text] [Related]  

  • 51. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation.
    Macdougall IC; Cooper AC
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():32-5. PubMed ID: 16281956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinicoimmunological disorders in patients with postinfarction left ventricular remodeling and chronic cardiac failure].
    Teplliakov AT; Bolotskaia LA; Dibirov MM; Stepacheva TA; Karaman NV; Vdovina TV; Shilov SN; Kuznetsova AV
    Ter Arkh; 2008; 80(11):52-7. PubMed ID: 19143193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-inflammatory trials in chronic heart failure.
    Aukrust P; Yndestad A; Ueland T; Damås JK; Gullestad L
    Heart Fail Monit; 2006; 5(1):2-9. PubMed ID: 16547529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Periodontal Res; 2009 Apr; 44(2):225-31. PubMed ID: 18973545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Device-based nonspecific immunomodulation therapy (Celacade), and its potential role in the treatment of chronic heart failure.
    Sporter RJ; Kim JH; Frishman WH
    Cardiol Rev; 2008; 16(6):280-7. PubMed ID: 18923231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
    Mumm JB; Oft M
    Oncogene; 2008 Oct; 27(45):5913-9. PubMed ID: 18836472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of bacterial endotoxin in chronic heart failure: the gut of the matter.
    Charalambous BM; Stephens RC; Feavers IM; Montgomery HE
    Shock; 2007 Jul; 28(1):15-23. PubMed ID: 17510602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
    Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T; Bartlova M; Krajickova J; Haluzikova D; Mraz M; Lacinova Z; Kudla M; Teplan V; Haluzik M
    Nutrition; 2009; 25(7-8):762-8. PubMed ID: 19539174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depression, cytokines, and glial function.
    Miller DB; O'Callaghan JP
    Metabolism; 2005 May; 54(5 Suppl 1):33-8. PubMed ID: 15877311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.